BCL2 and neoplasm: Hence, inhibitors specific for Bcl‐2 or Mcl‐1 have been developed as direct inducers for tumor cell apoptosis in chronic lymphocytic leukemia and small lymphocytic lymphoma, and hamper tumor progression both in patients and in tumor mouse models.77